BACK TO TOP
KSE100
167,691.08
-5478.63
(-3.16%)
KSE100PR
52,607.48
-1718.74
(-3.16%)
ALLSHR
100,605.79
-3347.16
(-3.22%)
KSE30
51,327.62
-1715.27
(-3.23%)
KMI30
234,255.58
-8675.81
(-3.57%)
BKTI
49,641.17
-1417.38
(-2.78%)
OGTI
33,066.32
-1093.65
(-3.20%)
KMIALLSHR
64,318.37
-2188.72
(-3.29%)
PSXDIV20
76,486.76
-1906.43
(-2.43%)
UPP9
59,094.62
-1974.90
(-3.23%)
NITPGI
43,930.74
-1360.09
(-3.00%)
NBPPGI
47,744.30
-1601.25
(-3.24%)
MZNPI
28,960.80
-1106.87
(-3.68%)
JSMFI
42,617.38
-1968.44
(-4.41%)
ACI
22,875.57
-922.09
(-3.87%)
JSGBKTI
69,986.37
-2337.01
(-3.23%)
HBLTTI
18,041.63
20-02-2026
10.99
(0.06%)
MII30
21,355.12
-761.18
(-3.44%)
Haleon Pakistan Limited
PHARMACEUTICALS
Rs.890.65
-10.19
(-1.13%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Mon, Feb 23, 2026 1:49 PM
REG
DFC
CSF
ODL
Open
895.00
High
906.00
Low
881.51
Volume
10,439
CIRCUIT BREAKER
810.76 — 990.92
DAY RANGE
881.51 — 906.00
52-WEEK RANGE ^
653.14 — 1,010.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
900.84
VAR
10.00
HAIRCUT
15.00
P/E Ratio (TTM) **
17.49
1-Year Change * ^
11.21%
YTD Change * ^
6.88%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.

KEY PEOPLE
Qawi NaseerCEO
Farhan Muhammad HaroonChairperson
Mashal MohammadCompany Secretary
ADDRESS

11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600

WEBSITE

www.haleon.pk

REGISTRAR

CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.

AUDITOR

M/s KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
104,254,597.55
Shares
117,054,508
Free Float
15,728,912
Free Float
13.44%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2025Transmission of Quarterly Report for the Period Ended 30 September 2025 View   PDF
Oct 27, 2025Financial Results for the Quarter Ended 30 September 2025 View   PDF
Aug 29, 2025Transmission of Quarterly Report for the Period Ended 30 June 2025 View   PDF
Aug 26, 2025Financial Results for the Quarter Ended 30 June 2025 View   PDF
Apr 30, 2025Transmission of Quarterly Report for the Period Ended 31 March 2025 View   PDF
DateTitleDocument
Feb 23, 2026Notice of Board of Directors Meeting - (Q4-2025) View   PDF
Oct 20, 2025Notice of Board of Directors Meeting - (Q3-2025) View   PDF
Aug 18, 2025Notice of Board of Directors Meeting - (Q2-2025) View   PDF
Apr 18, 2025Notice of Board of Directors Meeting - (Q1-2025) View   PDF
Mar 20, 2025CTC of Resolutions Passed in the Annual General Meeting 2024 View   PDF
DateTitleDocument
Jan 27, 2026Disclosure of Material Information View   PDF
Dec 3, 2025Disclosure of Material Information View   PDF
Nov 19, 2025Presentation for Corporate Briefing Session 2025 View   PDF
Nov 14, 2025Notice of Corporate Briefing Session 2025 View   PDF
Nov 14, 2025Credit of Second Interim Cash Dividend View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales37,205,89331,609,77627,507,21224,163,150
Profit after Taxation4,578,247995,586325,4112,134,334
EPS39.118.512.7818.23
Q3 2025Q2 2025Q1 2025Q3 2024
Sales10,562,88311,598,08710,029,8439,754,500
Profit after Taxation1,615,0061,623,1591,347,5961,329,784
EPS13.8013.8711.5111.36
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)34.4520.4017.4027.38
Net Profit Margin (%)12.313.151.188.83
EPS Growth (%)359.58206.12(84.75)69.11
PEG0.060.10(0.70)0.19

Payouts

Financial Reports